February 2010

Deals of the year 2009: High grade –Swiss pharma Roche provides cure for quality concerns


Swiss pharma's €12.66 billion bond perfect medicine in ultra-cautious market.



The rest of this article is available to subscribers only

Please Subscribe or take a Free Trial below.
Already a subscriber? Log in here.